医学
淋巴瘤
DNA测序
疾病
计算生物学
生物信息学
病理
基因
遗传学
生物
标识
DOI:10.1016/j.path.2023.01.010
摘要
Lymphoma is a clinically and biologically heterogeneous disease. Next-generation sequencing (NGS) has expanded our understanding of this heterogeneity at the genetic level, refining disease classification, defining new entities, and providing additional information that can be used in diagnosis and management. This review highlights some of the NGS findings in lymphoma and how they can be used as genetic biomarkers to aid diagnosis and prognosis and guide therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI